The role of intestinal microflora and probiotic bacteria in prophylactic and development of colorectal cancer
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2013, Vol 67, Issue 0
Abstract
The gut microbiota comprises a large and diverse range of microorganisms whose activities have a significant impact on health. It interacts with its host at both the local and systemic level, resulting in a broad range of beneficial or detrimental outcomes for nutrition, infections, xenobiotic metabolism, and cancer. The current paper reviews research on the role of intestinal microflora in colorectal cancer development. Especially a protective effect of beneficial bacteria and probiotics on the risk of cancer development is highly discussed. There is substantial experimental evidence that the beneficial gut bacteria and their metabolism have the potential to inhibit the development and progression of neoplasia in the large intestine. Most of the data derive, however, from experimental and animal trials. Over a dozen well-documented animal studies have been published, wherein it has been clearly revealed that some lactic acid bacteria, especially lactobacilli and bifidobacteria, inhibit initiation and progression of colorectal cancer. Studies on cancer suppression in humans as a result of the consumption of probiotics are still sparse. Nevertheless, some epidemiological and interventional studies seem to confirm the bacterial anticancerogenic activity also in human gut. The mechanism by which probiotics may inhibit cancer development is unknown. Probiotics increase the amount of beneficial bacteria and decrease the pathogen level in the gut, consequently altering metabolic, enzymatic and carcinogenic activity in the intestine, decreasing inflammation and enhancing immune function, which may contribute to cancer defense.
Authors and Affiliations
Ewa Wasilewska, Dagmara Złotkowska, Mariola E. Pijagin
Keywords
Related Articles
- EP ID EP67019
- DOI -
- Views 150
- Downloads 0
Perspektywy farmakoterapii chorób przebiegających z udziałem zaawansowanych produktów utleniania białek
Ze względu na stale wzrastającą liczbę doniesień o udziale zaawansowanych produktów utleniania białek (AOPPs) w patogenezie wielu chorób oraz patomechanizmie ich zaburzeń biochemicznych i powikłań klinicznych, obiektem i...
The role of nutrigenomics in obesity
Obesity and overweight is an emerging health problem of growing importance, and much promise for the prevention and treatment of this disease is connected with nutrigenomics. Nutrigenomics corresponds to the use of bioch...
The percentage of iNKT cells among other immune cells at various clinical stages of laryngeal cancer
Introduction: Invariant natural killer T (iNKT) cells constitute a small population of immune cells that share functional and phenotypic characteristics of T lymphocytes and NK cells. Due to their involvement in specific...
Characteristics of T lymphocyte subpopulations
The paper describes the characteristics, receptor profile and functions of T lymphocyte subpopulations (helper, cytotoxic, regulatory, memory and others). Among T helper cells one can enumerate Th0, Th1, Th2, Th9, Th17,...
Evidence for the efficacy of immunotherapy in children with high-risk neuroblastoma
Neuroblastoma is the most common extra-cranial malignancy of childhood, with the highest incidence in children younger than 4 years. The prognosis depends on many factors, such as age at diagnosis, stage of disease and m...